Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03063164 · ClinicalTrials.gov registry record · NA
A Comparison of LASIK Outcomes Using Two Femtosecond Lasers
A NA study, sponsored by Edward E. Manche.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03063164: Completed NA study, sponsored by Edward E. Manche.
NCT03063164 is a NA study that has completed, run by Edward E. Manche. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03063164, a NA study, has completed, sponsored by Edward E. Manche.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Comparing LASIK outcomes using two femtosecond lasers
Primary Outcome
Number of eyes with an uncorrected visual acuity of 20/20 at 12 months measured using ETDRS testing charts
Interventions
- DEVICE Intralase IFS150
- DEVICE Visumax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-02-14 |
| Est. Completion | 2018-11-13 |
| Phase | NA |
What the finished NCT03063164 record still lists
NCT03063164 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Intralase IFS150 is the first listed.
NCT03063164 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03063164 about?
NCT03063164 is a clinical study titled "A Comparison of LASIK Outcomes Using Two Femtosecond Lasers". Comparing LASIK outcomes using two femtosecond lasers
What is the current status of trial NCT03063164?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2017-02-14. Estimated completion is 2018-11-13.
What interventions are being tested in trial NCT03063164?
The interventions under investigation include: Intralase IFS150 (DEVICE), Visumax (DEVICE).
Who is sponsoring clinical trial NCT03063164?
This trial is sponsored by Edward E. Manche, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03063164's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI